ScholarIQanswers from OpenAlex
VIB-KU Leuven Center for Cancer Biology
InstitutionResearch output, impact & collaborations
VIB-KU Leuven Center for Cancer Biology is a institution indexed in ScholarIQ from OpenAlex.
What is known about VIB-KU Leuven Center for Cancer Biology?
ScholarIQrecord summary
VIB-KU Leuven Center for Cancer Biology is a research organisation in Leuven, BE. OpenAlex records 4,094 works and 1,139,088 citations for it. 860 researchers list it as their most recent affiliation.
How many works does VIB-KU Leuven Center for Cancer Biology have?
ScholarIQindexed works
VIB-KU Leuven Center for Cancer Biology has 4,094 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does VIB-KU Leuven Center for Cancer Biology have?
ScholarIQcitation count
VIB-KU Leuven Center for Cancer Biology has 1,139,088 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at VIB-KU Leuven Center for Cancer Biology?
ScholarIQresearcher count
VIB-KU Leuven Center for Cancer Biology has 860 researchers in the ScholarIQ index.
What is the average h-index at VIB-KU Leuven Center for Cancer Biology?
ScholarIQavg h-index
VIB-KU Leuven Center for Cancer Biology has an average h-index of 78.1 in OpenAlex.
What is the ROR of VIB-KU Leuven Center for Cancer Biology?
ScholarIQror
The ROR for VIB-KU Leuven Center for Cancer Biology is on the source record.
What is the OpenAlex record for VIB-KU Leuven Center for Cancer Biology?
ScholarIQopenalex
The OpenAlex for VIB-KU Leuven Center for Cancer Biology is on the source record.
Who are the most-cited researchers behind VIB-KU Leuven Center for Cancer Biology?
ScholarIQtop researchers by citations
What are the most-cited papers on VIB-KU Leuven Center for Cancer Biology?
ScholarIQmost cited works
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
Wendy De Roock, Bart Claes, David Bernasconi, Jef De Schutter, Bart Biesmans, George Fountzilas, Konstantine T. Kalogeras, Vassiliki Kotoula, Demetris Papamichael, Pierre Laurent‐Puig, Frédérique Penault–Llorca, Philippe Rougier, Bruno Vincenzi, Daniele Santini, Giuseppe Tonini, Federico Cappuzzo, Milo Frattini, Francesca Molinari, Piercarlo Saletti, Sara De Dosso, Miriam Martini, Alberto Bardelli, Salvatore Siena, Andrea Sartore‐Bianchi, Josep Tabernero, Teresa Macarulla, Frédéric FIORE, Alice Gangloff, Fortunato Ciardiello, Per Pfeiffer, Camilla Qvortrup, Tine Plato Hansen, Eric Van Cutsem, Hubert Piessevaux, Diether Lambrechts, Mauro Delorenzi, Sabine Tejpar
VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death
Diether Lambrechts, Erik Storkebaum, Masafumi Morimoto, Jurgen Del‐Favero, Frederik Desmet, Stefan L. Marklund, Sabine Wyns, Vincent Thijs, Jörgen Andersson, Ingrid van Marion, Ammar Al‐Chalabi, Stéphanie Bornes, Rhiannon Musson, Valerie K. Hansen, L. Beckman, Rolf Adolfsson, Hardev Pall, Hervé Prats, Séverine Vermeire, Paul Rutgeerts, Shigehiro Katayama, Takuya Awata, Nigel Leigh, Loı̈c Lang-Lazdunski, Mieke Dewerchin, Christopher E. Shaw, Lieve Moons, Robert Vlietinck, Karen Morrison, Wim Robberecht, Christine Van Broeckhoven, Désiré Collen, Peter M. Andersen, Peter Carmeliet
Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver
Li Lu, Ying Li, Soo Mi Kim, Wouter Bossuyt, Pu Liu, Qiong Qiu, Yingdi Wang, Georg Halder, Milton J. Finegold, Ju‐Seog Lee, Randy L. Johnson
Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy
Anna Rita Cantelmo, Lena-Christin Conradi, Aleksandra Brajic, Jermaine Goveia, Joanna Kalucka, Andreas Pircher, Pallavi Chaturvedi, Johanna Hol Fosse, Bernard Thienpont, Laure-Anne Teuwen, Sandra Schoors, Bram Boeckx, Joris Vriens, Anna Kuchnio, Koen Veys, Bert Cruys, Lise Finotto, Lucas Treps, Tor Espen Stav-Noraas, Francesco Bifari, Peter C. Stapor, Ilaria Decimo, Kim R. Kampen, Katrien De Bock, Guttorm Haraldsen, Luc Schoonjans, Ton J. Rabelink, Guy Eelen, Bart Ghesquière, Jalees Rehman, Diether Lambrechts, Asrar B. Malik, Mieke Dewerchin, Peter Carmeliet
Gain of function of mutant p53 by coaggregation with multiple tumor suppressors
Jie Xu, Joke Reumers, José R. Couceiro, Frederik De Smet, Rodrigo Gallardo, Stanislav G. Rudyak, Ann Cornelis, Jef Rozenski, Aleksandra Zwolińska, Jean‐Christophe Marine, Diether Lambrechts, Young‐Ah Suh, Frédéric Rousseau, Joost Schymkowitz
How much of the research on VIB-KU Leuven Center for Cancer Biology is open access?
ScholarIQopen access share
75%OPEN ACCESS